FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

1395741000168100: galcanezumab (AU substance)

Status: current, Primitive. Date: 31-Oct 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4221061000168111 galcanezumab (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4221071000168117 galcanezumab en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
galcanezumab Is a medicinal substance true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
galcanezumab has intended active ingredient True galcanezumab Inferred relationship Some 1
Emgality 120 mg/mL injection, 1 mL syringe has intended active ingredient True galcanezumab Inferred relationship Some 1779571518
Emgality 120 mg/mL injection, 1 mL syringe has Australian BoSS True galcanezumab Inferred relationship Some 1779571518
Emgality Autoinjector 120 mg/mL injection, 1 mL pen device has intended active ingredient True galcanezumab Inferred relationship Some 1128349342
Emgality Autoinjector 120 mg/mL injection, 1 mL pen device has Australian BoSS True galcanezumab Inferred relationship Some 1128349342
galcanezumab 120 mg/mL injection, pen device has intended active ingredient True galcanezumab Inferred relationship Some 1341257854
galcanezumab 120 mg/mL injection, pen device has Australian BoSS True galcanezumab Inferred relationship Some 1341257854
galcanezumab 120 mg/mL injection, syringe has Australian BoSS True galcanezumab Inferred relationship Some 310131170
galcanezumab 120 mg/mL injection, syringe has intended active ingredient True galcanezumab Inferred relationship Some 310131170

This concept is not in any reference sets

Back to Start